Change in BMI · children aged 7 years or over and adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Abdominal pain frequency or change in frequency · children aged 7 years or over and adults with cystic fibrosis
1 finding from 1 review
CFA: change from baseline (%) · children aged 7 years or over and adults with cystic fibrosis
1 finding from 1 review
Adverse events · children aged 7 years or over and adults with cystic fibrosis
1 finding from 1 review
Pulmonary exacerbations · children aged 7 years or over and adults with cystic fibrosis
Summary of findings: liprotamase showed no clear difference in pulmonary exacerbations: number of exacerbations compared with porcine PERT (low certainty).
1 finding from 1 review
Adverse events · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations · adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in weight (kg) · adults and children with cystic fibrosis
It is very uncertain whether summary of findings: ECM changes change in weight (kg) compared with ECT (very low certainty).
1 finding from 1 review
Change in height · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
24‐h ambulatory systolic BP · hyperuricaemia in people with hypertension
1 finding from 1 review
24‐h ambulatory diastolic BP · hyperuricaemia in people with hypertension
1 finding from 1 review
Systolic blood pressure · hyperuricaemia in people with hypertension
1 finding from 1 review
Diastolic blood pressure · hyperuricaemia in people with hypertension
1 finding from 1 review
Serum UA · hyperuricaemia in people with hypertension
1 finding from 1 review
Withdrawals due to adverse events · hyperuricaemia in people with hypertension
Uric acid‐lowering drug showed no clear difference in adverse events (withdrawals due to side effects) compared with placebo (low certainty).
1 finding from 1 review
Uterine fibroid‐related symptoms (abnormal uterine bleeding, measured at 12 weeks, with the pictorial blood assessment chart (PBAC); lower = better) · women with uterine fibroids
2 findings from 1 review
Adverse events (spotting at 3 and 6 months) · women with uterine fibroids
1 finding from 1 review
Uterine fibroid‐related symptoms (duration of uterine bleeding, measured at 12 weeks; lower = better) · women with uterine fibroids
1 finding from 1 review
Uterine fibroid‐related symptoms (abnormal uterine bleeding, measured at 12 weeks, with the pictorial blood assessment chart (PBAC); lower = better) · women with uterine fibroids
1 finding from 1 review
Fibroid size · women with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found